Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Identification of a novel 5-amino-3-(5-cyclopropylisoxazol-3-yl)-1-isopropyl-1H-pyrazole-4-carboxamide as a specific RET kinase inhibitor

Authors
Yoon, HojongShin, InjaeNam, YunjuKim, Nam DooLee, Kyung-BokSim, Taebo
Issue Date
5-1월-2017
Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
Keywords
RET kinase; Metabolic stability; Specific inhibitor; 5-Aminopyrazole-4-carboxamide
Citation
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.125, pp.1145 - 1155
Indexed
SCIE
SCOPUS
Journal Title
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume
125
Start Page
1145
End Page
1155
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/84945
DOI
10.1016/j.ejmech.2016.10.050
ISSN
0223-5234
Abstract
Activating mutations of REarrange during Transfection (RET) kinase frequently occur in human thyroid and lung cancers. An enormous effort has been devoted to discover potent and selective inhibitors of RET. Selective and potent inhibitors against constitutively active RET mutants are rare to date as identification of selective RET inhibitors is challenging. In a recent effort we identified a novel and specific RET inhibitor of 5-aminopyrazole-4-carboxamide scaffold, which was designed to enhance the metabolic stability of the pyrazolopyrimidine scaffold. In the SAR study described in the current report, we identified the 5-aminopyrazole-4-carboxamide analog 15l, which displays high metabolic stability. Compound 15l is potent against gatekeeper mutant (IC50 = 252 nM) of RET as well as against wild-type RET (IC50 = 44 nM). This substance effectively suppresses growth of Ba/F3 cells transformed with wild-type RET and its gatekeeper mutant (V804M), and thyroid-cancer derived IT cells while it does not affect parental Ba/F3 cells and Nthy ori-3-1, normal thyroid cells. Also, the results of a global kinase profiling assay on a panel of 369 kinases, show that 15l exclusively inhibits RET. Based on its exceptional kinase selectivity, great potency and metabolic stability, 15l represents a promising lead for the discovery of RET directed therapeutic agent and should be a key tool in studies aimed at understanding RET biology. (C) 2016 Elsevier Masson SAS. All rights reserved.
Files in This Item
There are no files associated with this item.
Appears in
Collections
Graduate School > KU-KIST Graduate School of Converging Science and Technology > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE